Videos

In this clip taken at the 2017 American Heart Association Meeting, Robert Carey, MD, of the University of Virginia discusses the expected increases in the population from the 2003 and 2017 guideline recommendations on hypertension.

At the American Heart Association's 2017 Scientific Sessions, Niteesh Kumar Choudhry, MD, PhD, Associate Professor at Harvard Medical School, presented the results of a study that evaluated a technology-enabled intervention conducted by pharmacists to help patients with chronic metabolic conditions adhere to their medications.

At the American Heart Association's 2017 Scientific Sessions, Niteesh Kumar Choudhry, MD, PhD, Associate Professor at Harvard Medical School, explained how pharmacists can use a behaviorally tailored method of patient interviewing to assess patients' adherence barriers.

Marc O’Connor, chief operating officer, Curant Health, discusses the best ways for pharmacies to succeed in the shift to value-based care.

In this clip, Dr. Whelton discusses the guideline's emphasis on a team-based approach to assessing and treating hypertension in patients.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses what pharmacy benefit managers look for in a specialty pharmacy.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses how data connectivity is crucial for the specialty pharmacy industry.

A look at last week's top stories in the world of pharmacy.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime speaks to how medication synchronization programs can improve adherence.

Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses promising specialty drugs to watch out for in the pipeline.

A look at last week's top stories in the world of pharmacy.

Marc O’Connor, chief operating officer at Curant Health, discusses the benefits of disruption within the specialty landscape.

David DeRemer, PharmD, Assistant Director of Clinical Therapeutics and Incubator, Clinical Associate Professor at the University of Florida College of Pharmacy, discusses resources to help educate patients on oral chemotherapy agents.

As a part of the continuing effort to increase awareness and celebrate the pharmacy profession, Pharmacy Times and Specialty Pharmacy Times are partnering to launch the #APharmacistIs campaign.

In this clip, Randy Burkholder, Vice President of Policy and Research at PhRMA, discusses the health care policy changes that are needed to help alleviate the financial hardships faced by cancer patients.

Pharmacists have an important role in the care of oncology patients, especially in managing their treatments and providing support to physicians.

At the National Community Oncology Dispensing Association (NCODA) Fall Summit, Mario Lacouture, MD, discussed the importance of managing quality of life conditions, such as skin, hair, and nail conditions, in patients undergoing cancer treatments.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, discusses what role pharmacists have in combating the opioid epidemic.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses the struggle with high-cost specialty medications and the alternatives for providing specialty pharmacy care.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, speaks to the merits of partnering with continuing education and advocacy organizations.

A look at last week's top stories in the world of pharmacy.

As part of American Pharmacists Month, an editor shares her story of how a pharmacist helped her through a scary drug reaction.

PQIs, developed by a team of NCODA clinical pharmacists, provide medication management tools that focus on specific issues associated with managing oral cancer drug therapies.

Grant Knowles, PharmD, vice president, Business Development, Ardon Health, discusses the potential impact biosimilars will have in health care.